General Enquiries 01223 870008 | Our Careline 0800 002 9002

Contact us: General Enq 01223 870008 or call our Careline 0800 002 9002

Health Professional | FAQ |

Kidney Cancer Scotland | Fundraise Now

Recently Diagnosed Find Support

Home
Kidney Cancer
Patient Support
Research & Training
Support Us
About Us
News
Contact

Home
Kidney Cancer
Patient Support
Research & Training
Support Us
About Us
News
Contact

Day

September 7, 2020

SMC approves combination therapy for patients in Scotland

Kidney Cancer Scotland add their voice to those praising the Scottish Medicine Consortium’s (SMC) approval of the therapy Keytruda (pembrolizumab) in combination...

Kidney Cancer UK

The Old Granary
Abington Park Farm
Great Abington
Cambridge
CB21 6AX

More Information

Our Give With Confidence Promise
Our Fundraising Promise
Information Policy
Press Office
Officers and Team Members

Legal Information

Terms & Conditions
Privacy
Our Complaints Policy
Cookie Policy
Our Ethical Policy

© 2014 - 2019 Kidney Cancer Care Ltd.
Kidney Cancer UK, Kidney Cancer Care and Kidney Cancer Scotland are trading titles of Kidney Cancer Care Ltd.
Postal Address: Kidney Cancer UK, The Old Granary, Park Farm, Great Abington, Cambridge, CB21 6AX
Kidney Cancer Care Ltd is a registered charity in England and Wales (1120146) and Scotland (SC043642)
Registered Office: The Old Granary, Park Farm, Great Abington, Cambridge, CB21 6AX. Company Number England and Wales (05937304)

QuestionPro powers business intelligence by providing free customer satisfaction survey templates.

^{Website and hosting by}Watch the Dot

Top

×

Dive straight into the feedback!
Login below and you can start commenting using your own user instantly

We would like to invite you to be kept up to date with news from the
charity by signing up to our newsletter. Please enter you email address below.

*By submitting your email address you are agreeing to us contacting you with news and appeals from Kidney Cancer

UK & Scotland. We will never share any of your information with any third parties.